Search clinical trials for: Placebo - SC

Total 53899 results

Seattle Children's Hospital

Recruiting

Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors

Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma | Refractory Primary Malignant Central Nervous System Neoplasm | Recurrent CNS Tumor, Adult | Recurrent, CNS Tumor, Childhood

United States
Universitair Ziekenhuis Brussel

Completed

Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.

Survival | Embryo Quality

Belgium
Janssen Research & Development, LLC

Completed

A Study of Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States, Spain, Netherlands, Sweden, Denmark, France
VA Connecticut Healthcare System

Completed

Cognitive Behavioral Therapy for Diabetic Neuropathic Pain

Diabetic Peripheral Neuropathic Pain

United States
Centocor, Inc.

Completed

A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease

Crohn Disease

United States, Canada, Belgium
Centre for Human Drug Research, Netherlands
Leiden University Medical Center; Leiden Academic Center for Drug Research,...

Completed

Adalimumab Microneedles in Healthy Volunteers

Pain | Injection Site

Netherlands
AbbVie

Completed

A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer

Small Cell Lung Cancer

United States, Japan, Korea, Republic of, Taiwan
Jordan F. Karp

Withdrawn

Deep Brain Stimulation to Relieve Depression (DRIVER)

Treatment Resistant Depression
University of Cologne
German Federal Ministry of Education and Research; Heinrich-Heine University... and other collaborators

Unknown

Psychological Intervention for Persons in the Early Initial Prodromal State

Schizophrenia | Psychosis

Germany
Manchester University NHS Foundation Trust
Northern Care Alliance NHS Foundation Trust

Recruiting

Enhanced Rehabilitation After Major Trauma (PROPERLY) (PROPERLY)

Major Trauma

United Kingdom
Marius Henriksen

Terminated

Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure (TOCIVID)

Corona Virus Disease

Denmark
AstraZeneca

Completed

Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis (OSTRO)

Nasal Polyposis

United States, Canada, Denmark, Belgium, Germany, Hungary, Austria, Poland
Eli Lilly and Company

Completed

A Study of Mirikizumab (LY3074828) in Healthy Participants

Healthy

United States
Bristol-Myers Squibb

Completed

Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

United States
Merck Sharp & Dohme LLC

Completed

Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062)

Hepatitis B
Baxter Healthcare Corporation
Halozyme Therapeutics

Completed

Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration (INFUSE-Cftrx)

Healthy
Columbia University
Einhorn Family Charitable Trust

Completed

Family Nurture Intervention in the NICU

Premature Birth | Obstetric Labor, Premature

United States
The University of Hong Kong

Completed

Promoting Smoking Cessation for Female Smokers in Hong Kong Through Training Female Youth SCRA

Smoking Cessation

China
Elastagen Pty Ltd

Completed

Safety Study of Three Formulations of the Dermal Implant ELAPR

Skin Conditions

Australia
Eli Lilly and Company

Completed

A Study of Mirikizumab in Healthy Chinese Participants

Healthy

China
AbbVie

Not yet recruiting

Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma
StemCells, Inc.

Terminated

Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

Age-Related Macular Degeneration | Geographic Atrophy

United States
Pfizer

Completed

A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy (ANDANTE)

Crohn's Disease

United States, Denmark, Ireland, Australia, Belgium, Israel, Italy, Canada, Czech Republic, Hungary, Germany, United Kingdom, Brazil, New Zealand, France, Greece, Switzerland, Romania
Celltrion

Completed

A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Bulgaria
UCB Pharma

Completed

Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy

Rheumatoid Arthritis

United States, Belgium, United Kingdom
Janssen Pharmaceutical K.K.

Completed

A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Japan
Columbia University

Completed

Family Nurture Intervention in the NICU at The Valley Hospital

Premature Birth | Obstetric Labor, Premature

United States
University of Helsinki
Helsinki University Central Hospital; University of Virginia; University of Jyvaskyla and other collaborators

Completed

Efficacy and Neural Basis of Music-based Neurological Rehabilitation for Traumatic Brain Injury (MUBI)

Traumatic Brain Injury (TBI)

Finland
StemCells, Inc.

Completed

Long-Term Follow-Up Study of Human Stem Cells Transplanted in Subjects With Connatal Pelizaeus-Merzbacher Disease (PMD)

Pelizaeus-Merzbacher Disease | PMD

United States
University Hospital, Ghent

Completed

Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints

Erosive Osteo-Arthritis

Belgium
Ege University

Completed

6-year Clinical Evaluation of Glass Ionomer Cements (GIS) With Resin Coating on Posterior Teeth (GIS)

Dental Caries
AbbVie

Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.

Crohn's Disease

United States, Canada, Israel, Taiwan, Japan, Korea, Republic of
AstraZeneca

Terminated

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

Crohn's Disease

United States, France, Italy, Belgium, Australia, Canada, Hungary, Russian Federation, Spain, Germany, Netherlands, Israel
Columbia University
National Institute on Minority Health and Health Disparities (NIMHD); Icahn... and other collaborators

Active, not recruiting

Music Intervention for Preterm Birth

Preterm Birth

United States
University of Iowa
University of Washington; University of Minnesota

Completed

Pre-Implementation Enhancement Strategy To Improve Teachers' Intention to Implement Evidence-Based Practices (SC-PIES)

Implementation Science | Child Behavior Disorders | Healthcare Providers | Adolescent Problem Behavior at School
University of Pittsburgh
West Penn Allegheny Health System

Completed

Reducing Depressive Symptoms in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States
Sanofi Pasteur, a Sanofi Company
Sanofi K.K.

Completed

Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years

Influenza

Japan
Medical Care Development, Inc.
London School of Hygiene and Tropical Medicine

Completed

Trial to Compare Effectiveness of 2 Insecticides in Preventing Malaria

Malaria
StemCells, Inc.

Completed

Study of Human Central Nervous System (CNS) Stem Cells Transplantation in Pelizaeus-Merzbacher Disease (PMD) Subjects

Pelizaeus-Merzbacher Disease

United States
Human Genome Sciences Inc.
GlaxoSmithKline

Completed

Study of Belimumab Administered Subcutaneously to Healthy Subjects

Healthy

United States
BeiGene

Recruiting

Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

China, Georgia, Moldova, Republic of
University of Adelaide

Completed

Daily vs Intermittent Restriction of Energy: Controlled Trial to Reduce Diabetes Risk (DIRECT)

Individuals at Risk of Developing Diabetes

Australia
University of South Florida

Unknown

Distress Tolerance Treatment for Substance Users

Substance Dependence

United States
StemCells, Inc.

Completed

Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)

Macular Degeneration | Age Related Macular Degeneration | AMD

United States
University of North Texas, Denton, TX

Recruiting

Examining Effects of a Therapeutic Focus on Positive Memories on Post-Trauma Health

Stress Disorders, Post-Traumatic | Affect | Memory

United States
RaND Biosciences

Not yet recruiting

A Phase 1/2 Study of SC-43 in Combination With Cisplatin

Advanced Biliary Tract Cancer | Advanced Non-small-cell Lung Cancer
Janssen Research & Development, LLC

Recruiting

Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma (MajesTEC-1)

Hematological Malignancies

United States, Netherlands, Spain, France, Sweden
Takeda

Completed

A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants

Healthy Volunteers

United States
Eli Lilly and Company

Withdrawn

A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis (LUCENT-ACT)

Ulcerative Colitis
The Lymphoma Academic Research Organisation
Roche Pharma AG

Completed

Follicular Lymphoma IV/SC Rituximab Therapy (FLIRT) (FLIRT)

Follicular Lymphoma

France

3

Subscribe